Skip to content

Pyroptosis and Ferroptosis in the Pathophysiology of Lymphedema

The Role of Pyroptosis and Ferroptosis in the Pathophysiology of Lymphedema

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06237907
Enrollment
120
Registered
2024-02-02
Start date
2023-09-20
Completion date
2026-01-12
Last updated
2024-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lymphedema

Brief summary

The project aims to compare the differences in the expression of cell death through apoptosis and iron-dependent cell death after the reduction of edema symptoms following lymphedema surgery in patients.

Detailed description

This project aims to investigate the expression of cell death through apoptosis and iron-dependent cell death in the subcutaneous adipose tissue of patients with lymphedema. The study also seeks to explore the roles of these processes among lymphatic endothelial cells, adipocytes, and macrophages, and their association with lymphedema, thus gaining insights into the pathophysiological mechanisms of lymphedema. Furthermore, the project aims to compare the differences in the expression of cell death through apoptosis and iron-dependent cell death after the reduction of edema symptoms following lymphedema surgery in patients.

Interventions

OTHERPatients underwent lymphedema surgery

Patients who have developed lymphedema and undergone lymphedema surgery.

OTHERPatients underwent surgery without LVA

For patients who have not experienced lymphedema but require surgery due to other disease such as cancer, trauma, chronic wounds, skin defects, etc.

Sponsors

Chang Gung Memorial Hospital
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
20 Years to 100 Years
Healthy volunteers
No

Inclusion criteria

* Control Group: Patients who have not experienced lymphedema but require surgery due to other diseases such as cancer, trauma, chronic wounds, skin defects, etc. * Experimental Group: Patients who have lymphedema and undergone lymphedema surgery.

Exclusion criteria

* 1\. Individuals with venous thrombosis, chronic heart failure, and renal failure. * 2\. Vulnerable populations, individuals with limited mobility, pregnant women, and minors. * 3\. Those expected to be unable to attend follow-up visits or complete the study smoothly. * 4\. Participants who express doubts about the trial and cannot provide satisfactory answers.

Design outcomes

Primary

MeasureTime frameDescription
The correlation between post-LVA volume reduction1 month after surgeryThe differences in expression of cell necrosis and iron-dependent cell death after lymphedema surgery were observed in patients, following alleviation of edema symptoms.

Countries

Taiwan

Contacts

Primary ContactChing-Hua Hsieh, PhD
m93chinghua@gmail.com+886-7-7317123

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026